Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry.
about
Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approachA Review: Proteomics in Nasopharyngeal CarcinomaThe use of proteomics to identify novel therapeutic targets for the treatment of disease.Early diagnostic protein biomarkers for breast cancer: how far have we come?Proteomics in clinical trials and practice: present uses and future promise.Display technologies: application for the discovery of drug and gene delivery agents.Self-assembled monolayers for MALDI-TOF mass spectrometry for immunoassays of human protein antigensUse of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations.Cancer screening: a mathematical model relating secreted blood biomarker levels to tumor sizes.SELDI-TOF serum proteomics and breast cancer: which perspective?Utility of mass spectrometry for proteome analysis: part I. Conceptual and experimental approaches.Diagnostic model of saliva protein finger print analysis of patients with gastric cancer.SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma.Detection of Colorectal Cancer by Serum and Tissue Protein Profiling: A Prospective Study in a Population at RiskIdentification of candidate molecular markers predicting chemotherapy resistance in non-small cell lung cancer.SELDI-TOF serum proteomics and colorectal cancer: a current overview.Use of anchorchip-time-of-flight spectrometry technology to screen tumor biomarker proteins in serum for small cell lung cancer.Reference spectra from squamous epithelium and connective tissue allow whole section proteomics analysis.Improving Detection Accuracy of Lung Cancer Serum Proteomic Profiling via Two-Stage Training Process.Identification of serum protein markers for breast cancer relapse with SELDI-TOF MS.Characterization of discriminatory urinary proteomic biomarkers for severe preeclampsia using SELDI-TOF mass spectrometry.Novel Sample Preparation for Mass Spectral Analysis of Complex Biological Samples.Comparative proteomic profiles of Aspergillus fumigatus and Aspergillus lentulus strains by surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS)Microfluidic LC device with orthogonal sample extraction for on-chip MALDI-MS detection.Primary study of lymph node metastasis-related serum biomarkers in breast cancer.Effect of Turkish propolis extracts on proteome of prostate cancer cell line.Lack of a 5.9 kDa peptide C-terminal fragment of fibrinogen α chain precedes fibrosis progression in patients with liver disease.Discriminating active from latent tuberculosis in patients presenting to community clinics.Potential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches.Moving forward in colorectal cancer research, what proteomics has to tell.Novel translational strategies in colorectal cancer research.Protein profiling of blood samples from patients with hereditary leiomyomatosis and renal cell cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.New ionization processes and applications for use in mass spectrometry.Advances in molecular analysis of biomarkers for autoimmune and carcinogenic diseases.Potential Serum Markers for Monitoring the Progression of Hepatitis B Virus-Associated Chronic Hepatic Lesions to Liver Cirrhosis.Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer.Novel possibilities in the study of the salivary proteomic profile using SELDI-TOF/MS technology.Non-invasive proteomics-thinking about personalized breast cancer screening and treatmentSerum proteomics and disease-specific biomarkers of patients with advanced gastric cancer.Biomarker method validation in anticancer drug development
P2860
Q24337286-27ABD278-2BCF-4BF3-9973-F92A13A08C75Q26800017-FC5F6BBA-870C-4D4B-B552-DC61C64987CEQ30361936-EAFB4256-1A15-42B7-B0C9-3AD83542FFE2Q31043570-0F2AD197-DEB4-4CE9-ABFC-D70D0E450B3FQ33245305-51F946F1-FF15-4418-B5C1-C512F89FAC22Q33264491-979C4967-2F2A-4832-AE15-D14B836730E3Q33289397-F6ED4FA8-BBC0-4C55-81ED-C65CE769DB85Q33304365-CF9E18BC-EC05-4426-960A-E8188A4C5507Q33361745-19EC6905-B597-446D-86C2-6DFDD88A3FACQ33393365-73812910-8BFF-462A-AB32-F25A2B9F5875Q33393366-C3623649-9182-41BF-889A-B058B5784699Q33410879-73A65E80-C86D-4C0C-A6E1-D0FCD5A26A94Q33470022-5B3CC5D8-F626-4782-8369-10A748C206D3Q33478415-82B19069-8CB6-404C-A854-F929808985F0Q33546556-C255709E-1155-4403-A962-AF642D5B2B76Q33628047-4CB453A3-D69D-4077-90B0-E6392DC9B27BQ33696558-FE27C613-8B76-4CBA-AD61-F946FBFCF1D5Q33748119-B9FBFBAB-A5FC-4A77-A89C-1CB9E7BE9503Q33874499-9BEC7B7D-A8A0-4FD6-9BFE-12B6D583E5B0Q33891208-E5C0BA0A-8089-4A10-9F5C-CAA3181073D4Q33894249-6E199528-BB26-443B-AEC8-D61552722D90Q33952033-5243EC2E-2BD4-44A1-B9E2-8BE41FF4F89FQ33974176-E3D1A37B-A2C1-4889-9706-F92E0251D1F2Q34010313-227698AF-9A2C-40B4-B026-4BB3BCFED72DQ34037335-E9CE5CDF-AB94-4B0C-B9FF-17B37B3C9445Q34094841-F99C58E1-05BB-4FBB-806B-88D74DD9A23AQ34282455-B4C19FFC-62C4-47EF-AAD2-398BE6B11F4FQ34292798-12198EF6-1A8E-4C62-AE80-C69FE63A6885Q34305848-C3C9C322-FDD8-4E14-B918-4A4EB9F8D88BQ34382769-8A2FD307-9DE3-47D1-ACFA-1F25530E3281Q34382804-C61F8AC7-20EC-4DBA-899C-92022BD86DDFQ34497888-9E031BEF-2A2C-43E2-B563-06F5494382A7Q34863434-D5C2E1D7-1DE0-4AB0-AAB5-B2B823A7A8FAQ35043145-2C99E02B-9D7B-4F81-B0F5-1E7F22C85830Q35627301-3EAD4A08-2B7D-42A1-B19F-D2BAF17017A9Q35867858-87044DA7-3225-432D-A790-0AA3F4FBC4FEQ35964447-EDB190DB-F54E-4D3F-8CE1-C55B04647507Q36117711-0E39283C-FF45-4F2E-AAF8-10988C664144Q36216932-B014FEB2-5FD0-450C-8E51-D926864AF54CQ36484621-0AAB4859-2408-4932-AC75-2E8444C928C1
P2860
Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Clinical proteomics: searching ...... h SELDI-TOF mass spectrometry.
@ast
Clinical proteomics: searching ...... h SELDI-TOF mass spectrometry.
@en
type
label
Clinical proteomics: searching ...... h SELDI-TOF mass spectrometry.
@ast
Clinical proteomics: searching ...... h SELDI-TOF mass spectrometry.
@en
prefLabel
Clinical proteomics: searching ...... h SELDI-TOF mass spectrometry.
@ast
Clinical proteomics: searching ...... h SELDI-TOF mass spectrometry.
@en
P2093
P1476
Clinical proteomics: searching ...... h SELDI-TOF mass spectrometry.
@en
P2093
Jan H M Schellens
Jos H Beijnen
Judith Y M N Engwegen
Marie-Christine W Gast
P304
P356
10.1016/J.TIPS.2006.03.003
P577
2006-04-04T00:00:00Z